https://www.selleckchem.com/pr....oducts/fph1-brd-6125
Abnormal P53 and SMARCB1 (INI1) expression was noted in patient 3. All three patients underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy, and two received postoperative chemotherapy and/or radiation therapy. The patients survived disease-free for 60, 26 and 15 months, respectively. Dedifferentiated endometrioid carcinomas with neuroendocrine differentiation may be associated with mismatch repair deficiency and have an improved prognosis. Dedifferentiated endometrioid carcinomas with neuroendocrine different
Me gusta
Comentario
Compartir
